NCT02197689

Brief Summary

Taiwan has attracted much attention for its National Health Insurance (NHI) and healthcare system around the world with many countries in Europe and the United States using it as a benchmark. However, increasing medication costs over the past two years account for more than 25% of total expenditure, surpassing every OECD member and mounting increasing pressure on the NHI. Nevertheless, patient medication adherence is relatively low. Thus, the investigators assessed the effectiveness of a personalized medication management system for improving the medication adherence for patients, in order to save long term medication costs.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
763

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2010

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

July 17, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 23, 2014

Completed
Last Updated

July 23, 2014

Status Verified

June 1, 2014

Enrollment Period

2.5 years

First QC Date

July 17, 2014

Last Update Submit

July 22, 2014

Conditions

Patients Take Medicine

Keywords

Personalized Medication ManagementMedication AdherenceSMS Medication Reminder

Outcome Measures

Primary Outcomes (1)

  • The proportion of patients in delaying and forgetting medications

    Patients who participated in this trial will be sent SMS during 7days

Study Arms (2)

SMS Medication Reminder

EXPERIMENTAL

763 patients were assigned to experimental group

Device: Personalized Medication Management Platform for SMS Reminder

No SMS Reminder

NO INTERVENTION

435 patients were assigned to control group as no SMS reminder

Interventions

Personalized Medication Management Platform for SMS ReminderDEVICE

The Personalized Medication Management Platform was developed by investigators that integrated with Hospital Information System (HIS) to collect the prescription information of patients and automatically send SMS to remind

SMS Medication Reminder

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Delayed or forgot to take medications over the last 3 days
  • Received a min. 7-day medication prescription
  • Able to receive SMS using mobile phones / devices
  • years or older
  • Having intention to receive active treatment

You may not qualify if:

  • Unable to receive SMS via mobile phones
  • Illiterate and \< 20 years of age
  • Received outpatient prescription drugs for ≤ 7 days
  • External use, injections and traditional Chinese medicine
  • Planned to go abroad
  • Cold, cough, or prescribed with analgesics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Huang CY, Nguyen PA, Clinciu DL, Hsu CK, Lu JR, Yang HC, Wu CC, Tsai WC, Chou YC, Kuo TBJ, Chang PL, Jian WS, Li YJ. A personalized medication management platform (PMMP) to improve medication adherence: A randomized control trial. Comput Methods Programs Biomed. 2017 Mar;140:275-281. doi: 10.1016/j.cmpb.2016.12.012. Epub 2016 Dec 30.

    PMID: 28254084DERIVED

MeSH Terms

Conditions

Medication Adherence

Condition Hierarchy (Ancestors)

Patient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Yu-Chuan Li, MD., PhD

    Taipei Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2014

First Posted

July 23, 2014

Study Start

January 1, 2010

Primary Completion

July 1, 2012

Study Completion

November 1, 2012

Last Updated

July 23, 2014

Record last verified: 2014-06